论文部分内容阅读
With improved outcomes associated with radiotherapy,radiation-induced sarcomas(RIS)are increasingly seen in long-term survivors of head and neck cancers,with an estimated risk of up to 0.3%.They exhibit no subsite predilection within the head and neck and